Sign in
Taking people in United StatesNo phase

GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

Key facts

Who runs it
W.L.Gore & Associates
Where
Baltimore, Boston, Chapel Hill, Durham, Gainesville, Hartford, Houston, Lakeland, Los Angeles, Madison, Milwaukee, Murray, Palo Alto, Philadelphia, Pittsburgh, Plano, Portland, Sacramento, Santa Barbara, Scottsdale, Seattle, Tampa, and Washington D.C., United StatesSee the 25 sites
Trial code
Status
Recruiting
People taking part
125 people, planned
Started
2 Mar 2026
Expected to end
Mar 2036
Type of study
Interventional
Treatments tested
  • GORE® TAG® Thoracic Branch Endoprosthesis
Record updated
12 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements
  • Patient has been or is intended to be treated with the TBE Device in Zone 0 or Zone 1
  • Patient is age ≥ 18 years at time of informed consent signature

Who cannot take part

  • Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or investigational device study within 12 months of study enrollment. Subjects cannot be enrolled in another Gore study
  • Patient who is, at the time of consent, unlikely to be available for defined follow-up visits
  • Patient with exclusion criteria required by local law

Where in United States

  • Johns Hopkins UniversityBaltimore, United StatesContact: Mehrdad Ghoreishi, MDTaking people
  • University of Maryland School of MedicineBaltimore, United StatesContact: Shahab Toursavadkohi, MDTaking people
  • Massachusetts General HospitalBoston, United StatesContact: Jahan Mohebali, MDTaking people
  • University of North Carolina at Chapel HillChapel Hill, United StatesContact: Mark Farber, MDTaking people
  • Duke University Medical CenterDurham, United StatesContact: G. Chad Hughes IV, MDTaking people
  • University of Florida Health Heart & VascularGainesville, United StatesContact: Martin Back, MDTaking people
  • Hartford HospitalHartford, United StatesContact: Akhilesh Jain, MDTaking people
  • Baylor College of MedicineHouston, United StatesContact: Steven Maximus, MDTaking people
  • The Methodist Hospital - HoustonHouston, United StatesContact: Marvin Atkins, MDTaking people
  • Lakeland Regional Medical CenterLakeland, United StatesContact: Mohammed Hassan, MDTaking people
  • Keck Medical Center of USCLos Angeles, United StatesContact: Sukgu Han, MDTaking people
  • University of Wisconsin - MadisonMadison, United StatesContact: Kyla Bennett, MDTaking people
  • Medical College of WisconsinMilwaukee, United StatesContact: Peter Rossi, MDTaking people
  • Intermountain Medical CenterMurray, United StatesContact: Jane He, MDTaking people
  • Stanford University Hospital and ClinicsPalo Alto, United StatesContact: A. Claire Watkins, MDTaking people
  • Thomas Jefferson UniversityPhiladelphia, United StatesContact: Cecilia Chin, MDTaking people
  • Allegheny General HospitalPittsburgh, United StatesContact: Bart Chess, MDTaking people
  • Baylor Scott & White Research InstitutePlano, United StatesContact: Justin Schaffer, MDTaking people
  • Oregon Health Science UniversityPortland, United StatesContact: Sherene Shalhub, MDTaking people
  • University of California Davis Health SystemSacramento, United StatesContact: Andrew Barleben, MDTaking people
  • Santa Barbara Cottage Research InstituteSanta Barbara, United StatesContact: Michael Paisley, MDTaking people
  • HonorHealthScottsdale, United StatesContact: Hasan Aldailami, MDTaking people
  • University of Washington Medical CenterSeattle, United StatesContact: Matthew Sweet, MDTaking people
  • University of South FloridaTampa, United StatesContact: Halim Yammine, MDTaking people
  • MedStar Washington Hospital CenterWashington D.C., United StatesContact: William Yoon, MDTaking people

About the trial

What the trial wants to find out

A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.

The group in the trial

  • GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device)Other group

    Treatment: GORE® TAG® Thoracic Branch Endoprosthesis

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
12 November 2026